The annual New Horizons Forum unites clinical, industry, financial, and FDA leaders in a unique exchange on research innovation and advances in glaucoma treatment. The Drs. Henry and Frederick Sutro Memorial Lecture, the keynote talk at New Horizons, features current opinion leaders and innovators in the field of glaucoma.
How Can You Participate in the Future of Glaucoma Care?
Learn what happens when doctors, patients, entrepreneurs, industry leaders, funders, and regulators share ideas at the New Horizons Forum, a one-of-a-kind innovation incubator.
Steven Vold, MD: This is a very unique meeting, because what it does is it brings innovative doctors, it brings industry executives, and then you also have the venture firms that can actually make these things happen. It really allows for further innovation and really hopefully advances our field and the treatment of our glaucoma patients in a more rapid-fire fashion.
Eydie Miller-Ellis, MD: What makes it different from other ophthalmology meetings is its emphasis on innovation, it’s exciting to see really what the future holds. It makes me a lot more hopeful about the future of glaucoma care because there’s a lot of really exciting technology out there.
Joel Schuman, MD, FACS: So there are so many different things that Glaucoma Research Foundation does. And this meeting is a good example of being a catalyst to join industry and clinicians. And I think that it’s very important that the two camps be able to benefit from each other’s knowledge and skillsets.
Ronald L. Gross, MD: This is a great meeting because normally I’m a glaucoma specialist, and we go to meetings with other glaucoma specialists, and we all talk about things and we have really very little idea of what’s coming down the pike, what’s in the road to development. This is much different in that these were all companies that many of us knew little or nothing about, and they were willing to come forward and give us their ideas and to show what potentially will be coming to the clinical world over the next several years. There’s really no other place that we have that ability to be able to get that look into the future.
Richard L. Lindstrom, MD: I think these kinds of meetings, which we’ve been doing the last few years, where we all are in the same room and the FDA listens to the entrepreneur and the startup company CEO, and then the clinicians and scientists have their input as well, has really helped a lot for us each to understand each other’s challenges.
Eve Higginbotham, SM, MD: One of the things I would encourage anyone out there, who hasn’t been to this meeting, is to really put it on your calendar and consider coming. Because it is an opportunity in a very intimate setting to reconnect with colleagues in a way that is going to generate new ideas as well as potentially new inventions that can change our patient’s lives.
End of transcript.
Friday, February 9, 2024
7:00 am – 7:00 pm
New Horizons Forum and all other Glaucoma 360 events will be held at the Westin St. Francis San Francisco on Union Square, 335 Powell Street, in downtown San Francisco, California.
Contact Maxson Thomas for information about sponsorship opportunities for New Horizons Forum.
For more information:
WHO SHOULD ATTEND
• Early-stage company CEOs and executives
• Business Development and other representatives from companies that offer pharmaceuticals, devices, drug delivery, and IOP monitoring for glaucoma patients
• Clinicians and other key opinion leaders
• Industry Executives
• Venture Capitalists
• Representatives from Clinical Research Organizations
• Scientific innovators
2024 KEYNOTE ADDRESS
The Drs. Henry and Frederick Sutro Memorial Lecture
“The Innovation Journey of an iDoctor”
Sean Ianchulev, MD, MPH
Professor of Ophthalmology, Director of Innovation and Technology, New York Eye and Ear of Mount Sinai, Icahn School of Medicine; Founder and Chairman, Eyenovia, Inc., Iantrek, Inc., RemoniHealth, Inc.
Adrienne Graves, PhD
Glaucoma 360 Co-Founder and Co-Chair
Chairman, Retinal Degeneration Fund; Board of Directors, Glaucoma Research Foundation, Implandata, JelliSee, Nicox, NVasc, Ocular Therapeutix, Opus Genetics, Surface Ophthalmics, Qlaris Bio, and TherOptix
Andrew G. Iwach, MD
Glaucoma 360 Founder and Co-Chair
Glaucoma Center of San Francisco
Chair, Board of Directors
Glaucoma Research Foundation
Nationally and internationally respected leaders in the field of glaucoma, business, and medical innovation provide leadership for the Glaucoma 360 New Horizons Forum. The Advisory Board is actively involved, along with the Glaucoma 360 Program Committee, in planning the meeting and recommending engaging speakers, noteworthy panelists, and timely topics.